Millrace Asset Group’s DermTech, Inc. Common Stock DMTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-12,606
Closed -$46K 68
2023
Q1
$46K Buy
+12,606
New +$53.1K 0.05% 54
2022
Q4
Sell
-209,158
Closed -$828K 64
2022
Q3
$828K Buy
209,158
+182,640
+689% +$1.12M 1.05% 42
2022
Q2
$147K Sell
26,518
-204,566
-89% -$1.68M 0.14% 60
2022
Q1
$3.39M Buy
231,084
+208,712
+933% +$2.79M 2.47% 5
2021
Q4
$353K Sell
22,372
-3,300
-13% -$79.3K 0.21% 79
2021
Q3
$824K Buy
25,672
+526
+2% +$18.5K 0.51% 64
2021
Q2
$1.04M Buy
25,146
+3,427
+16% +$141K 0.55% 74
2021
Q1
$1.1M Sell
21,719
-37,913
-64% -$1.98M 0.59% 74
2020
Q4
$1.93M Sell
59,632
-190,396
-76% -$2.7M 1.35% 35
2020
Q3
$2.99M Buy
250,028
+131,849
+112% +$1.53M 2.41% 3
2020
Q2
$1.56M Buy
+118,179
New +$1.54M 1.6% 24

Other funds holding DMTK

Millrace Asset Group's DMTK Position: Q2 2023 in Review

Millrace Asset Group sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2023, closing a stake of 12,606 shares — an estimated $46K sold.

Millrace Asset Group first reported a position in DMTK in Q2 2020 and held it in 11 quarters. The position peaked at $3.39M in Q1 2022. 85 funds tracked by Wall St. Rank hold DMTK as of Q2 2023.

  • Millrace Asset Group reported no remaining DermTech, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Millrace Asset Group sold 12,606 DermTech, Inc. Common Stock shares in Q2 2023, an estimated $46K.
  • Millrace Asset Group first reported a position in DermTech, Inc. Common Stock in Q2 2020 and held it in 11 quarters.
  • Millrace Asset Group's DermTech, Inc. Common Stock position peaked at $3.39M in Q1 2022.
  • 85 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2023.

Based on Millrace Asset Group's 13F filing for Q2 2023, filed 14 Aug 2023.